The AlphaFold Server is available to non-commercial researchers globally for predicting structures and interactions.
Mostly true True in substance, wrong in a detail.
Factual: Statements about the present or the past, checked against the record: did they hold up?
The second judge would not resolve this claim; the verdict shown is the first judge's.
Said for an organisation they lead or work for; it counts on both records.
What would count as true or false
Judge as of 2025-11-25. True: the AlphaFold Server was live, free to use for non-commercial research, open to users in most countries worldwide, and able to predict structures and interactions (e.g. protein complexes with DNA, RNA or ligands). Mostly true: it was available as stated but with notable limits in some countries or regions, or limits on which kinds of interactions it supports. Mixed: access was limited to a fairly small set of regions or users. Mostly false: it existed but access was heavily restricted (e.g. invitation-only) or it was down at that date. False: no such server was publicly available to non-commercial researchers at that date.
Set before the research began.
Evidence (8)
-
E1 [PDF] AlphaFold Server Additional Terms of Service - Gstatic.com Google (gstatic.com, AlphaFold Server terms document) · 8 May 2024 Own record
“AlphaFold Server is a research tool available free of charge to non-commercial users. It generates 3D structure predictions of biological molecules”
-
E2 AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers GEN (Genetic Engineering & Biotechnology News) · 13 June 2024
“Upon launch, the AlphaFold Server also imposed a daily limit of 10 requests per day. While that number later increased to 20”
-
E3 AlphaFold 3 Angst: Limited Accessibility Stirs Outcry from Researchers GEN (Genetic Engineering & Biotechnology News) · 13 June 2024
“ligand inputs to the web server were limited to a finite list of biological molecules and did not allow custom inputs, such as small molecule drugs.”
-
E4 Google's year in review: 8 areas with research breakthroughs in 2025 Google (blog.google) · 23 December 2025 Own record
“AlphaFold has been used by over 3 million researchers in more than 190 countries, including over 1 million users in low- and middle-income countries.”
-
E5 AlphaFold Google DeepMind Own record
“At the same time, Google DeepMind launches AlphaFold Server, a platform that provides scientists free access to AF3 structure prediction capabilities for non-commercial research.”
-
E6 AlphaFold Google DeepMind Own record
“Meanwhile, AlphaFold Server predicts how proteins will interact with a broad spectrum of biomolecules, accelerating new research.”
-
E7 AlphaFold Google DeepMind Own record
“AlphaFold is being used by over 3 million researchers from over 190 countries around the world, tackling problems such as antimicrobial resistance, crop resilience and heart disease.”
-
E8 AlphaFold Is Free. Patient-Led Labs Are Using It. — Ascero AI News Ascero AI News · 28 May 2026
“The AlphaFold Server runs it through a browser. There is a daily request cap and a non-commercial license, but for a patient advocacy group running ten or twenty searches a week against candidate drug compounds, the cap is not the binding constraint.”
Reasoning
Google's own terms and DeepMind pages describe AlphaFold Server as a free tool for non-commercial users that predicts 3D structures and how proteins interact with other biomolecules (E1, E6, E7). Independent reporting from 2024 confirms the server was operating, but with a daily request cap and ligand inputs restricted to a fixed list that excluded custom small molecules such as drugs (E3, E4). A 2026 independent article still describes it as a free, browser-based tool with a non-commercial licence and a daily cap (E9), which is consistent with it being live on the judge date. The 190-country usage figures refer to AlphaFold in general rather than to the Server specifically (E5, E8). Given a 2024 report that the server accepted ligand inputs only from a fixed list [E4], and a daily request cap that is still described in 2026 [E3][E9], the verdict is mostly true rather than fully true.
Cite this claim
Demis Hassabis, “The AlphaFold Server is available to non-commercial researchers globally for predicting structures and interactions.” (said 25 November 2025). Verdict: mostly true. Reliability API, claim c_e8cd21506a9a, method 0.1.0+c876030c, dataset release v1.1.2. https://epistacklabs.com/claims/c_e8cd21506a9a
This claim is in dataset release v1.1.2, with the same verdict.
Reply to this claim
More factual claims by Demis Hassabis
-
Mostly true
“what’s important about them is their 3D structure.”
A protein's 3D structure is what determines, or partially determines, its function.
-
Resolved true
“So over 3 million scientists are now using AlphaFold.”
-
Resolved true
“Only about 10% of drugs actually get through all the clinical stages.”
Only about 10% of drugs get through all the clinical stages.
-
Mostly true
“Our AlphaProteo model can design novel, high-strength protein binders that target diverse molecules – including those associated with cancer and diabetes.”
-
Resolved true
“And one year later, we released AlphaFold 2’s predictions for more than 200 million protein structures, achieving what would take hundreds of millions of years to solve experimentally.”
Verdicts are made automatically; how verdicts are made.